Approach targets both the H and N portions of the virus
Promising new research announced by Rensselaer Polytechnic Institute could provide an entirely new tool to combat the flu. The discovery is a one-two punch against the illness that targets the illness on two fronts, going one critical step further than any currently available flu drug. Read more.
For more than 10 years, Mark Wentland professor of chemistry and chemical biology, led a Rensselaer team in the discovery of a family of novel opioid receptor compounds with the potential to treat nervous system disorders and addiction. The family of compounds was licensed to Alkermes Inc. and clinical trials began in December 2008.
Wentland and his team continue to work with Alkermes to develop the existing family of compounds, as well as identify back-up and/or second-generation drugs for possible application to other diseases. Read more.
Professor of Chemistry and Chemical Biology Mark Platt provides important clues as to why some otherwise healthy males might encounter fertility issues.
A journal issue co-edited by a human-computer interaction (HCI) professor from Rensselaer explores the promises and perils ahead for children in technological environments.
Researchers at Rensselaer Polytechnic Institute have developed a new method for using computer graphics to simulate and render an accurate visualization of a lunar eclipse.
The Lighting Research Center has tested a goggle-like device that delivers blue light directly to the eyes to improve sleep quality in older adults.
Rensselaer Research Review is published by the Division of Strategic Communications & External Relations (SCER). Web site design by Steven Morris, SCER Web Communications. Produced by Ellen Katzman, Web Producer. Edited by Colleen Carey ’01, Web Producer. Podcast by Colleen Carey ’01.
